211 related articles for article (PubMed ID: 15974943)
1. Dual COX-inhibitors: the answer is NO?
Fiorucci S; Antonelli E
Curr Top Med Chem; 2005; 5(5):487-92. PubMed ID: 15974943
[TBL] [Abstract][Full Text] [Related]
2. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Kwiecień S; Pajdo R; Ptak A; Pawlik M; Hahn E
Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
[TBL] [Abstract][Full Text] [Related]
3. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
[TBL] [Abstract][Full Text] [Related]
4. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
Ukawa H; Yamakuni H; Kato S; Takeuchi K
Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
[TBL] [Abstract][Full Text] [Related]
5. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
6. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S; Santucci L; Distrutti E
Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
[TBL] [Abstract][Full Text] [Related]
7. A magic bullet for mucosal protection...and aspirin is the trigger!
Wallace JL; Fiorucci S
Trends Pharmacol Sci; 2003 Jul; 24(7):323-6. PubMed ID: 12871661
[No Abstract] [Full Text] [Related]
8. Cox-2-selective inhibitors: the new super aspirins.
DeWitt DL
Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
[No Abstract] [Full Text] [Related]
9. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
10. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
11. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donors.
Perini R; Fiorucci S; Wallace JL
Can J Gastroenterol; 2004 Apr; 18(4):229-36. PubMed ID: 15054499
[TBL] [Abstract][Full Text] [Related]
13. The future of NSAID therapy: selective COX-2 inhibitors.
Vane JR; Botting RM
Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
[No Abstract] [Full Text] [Related]
14. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis.
Souza MH; de Lima OM; Zamuner SR; Fiorucci S; Wallace JL
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G54-61. PubMed ID: 12637254
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
Whittle BJ
Fundam Clin Pharmacol; 2003 Jun; 17(3):301-13. PubMed ID: 12803569
[TBL] [Abstract][Full Text] [Related]
16. NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
Zacharowski P; Breese E; Wood E; Del Soldato P; Warner T; Mitchell J
Eur J Pharmacol; 2005 Jan; 508(1-3):7-13. PubMed ID: 15680249
[TBL] [Abstract][Full Text] [Related]
17. Rational use of analgesic and antiinflammatory drugs.
Crofford LJ
N Engl J Med; 2001 Dec; 345(25):1844-6. PubMed ID: 11752364
[No Abstract] [Full Text] [Related]
18. NO-NSAIDs: from inflammatory mediators to clinical readouts.
Fiorucci S; Antonelli E
Inflamm Allergy Drug Targets; 2006 Apr; 5(2):121-31. PubMed ID: 16613571
[TBL] [Abstract][Full Text] [Related]
19. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).
Harris RE; Beebe-Donk J; Doss H; Burr Doss D
Oncol Rep; 2005 Apr; 13(4):559-83. PubMed ID: 15756426
[TBL] [Abstract][Full Text] [Related]
20. COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs.
Fiorucci S; Distrutti E
Curr Med Chem; 2011; 18(23):3494-505. PubMed ID: 21756233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
